Drug Shortage Report for TEVA-ROSUVASTATIN
Report ID | 195443 |
Drug Identification Number | 02354624 |
Brand name | TEVA-ROSUVASTATIN |
Common or Proper name | TEVA-ROSUVASTATIN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | PP3 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-06-19 |
Estimated end date | 2023-10-20 |
Actual end date | 2023-07-20 |
Shortage status | Resolved |
Updated date | 2023-07-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v20 | 2023-07-21 | English | Compare |
v19 | 2023-07-20 | French | Compare |
v18 | 2023-07-20 | English | Compare |
v17 | 2023-07-12 | French | Compare |
v16 | 2023-07-12 | English | Compare |
v15 | 2023-07-04 | French | Compare |
v14 | 2023-07-04 | English | Compare |
v13 | 2023-07-04 | French | Compare |
v12 | 2023-07-04 | English | Compare |
v11 | 2023-06-22 | French | Compare |
v10 | 2023-06-22 | English | Compare |
v9 | 2023-06-22 | French | Compare |
v8 | 2023-06-22 | English | Compare |
v7 | 2023-06-22 | French | Compare |
v6 | 2023-06-22 | English | Compare |
v5 | 2023-06-22 | French | Compare |
v4 | 2023-06-22 | English | Compare |
v3 | 2023-06-20 | English | Compare |
v2 | 2023-06-19 | French | Compare |
v1 | 2023-06-19 | English | Compare |
Showing 1 to 20 of 20